USADA announced today that Jordan Adel, of McKinney, Texas, an athlete in the sport of weightlifting, has accepted a three-year period of ineligibility for an anti-doping rule violation.
Adel, 32, tested positive for ibutamoren, ostarine (enobosarm), and LGD-4033 (ligandrol) and its metabolite di-hydroxy-LGD-4033, as the result of an out-of-competition urine sample collected on October 12, 2021. Ostarine and LGD-4033 are Non-Specified Substance in the class of Anabolic Agents, while ibutamoren is a Non-Specified Substance in the class of Peptide Hormones, Growth Factors, Related Substances, and Mimetics. These substances are prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policy, and the International Weightlifting Federation Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.
Under Article 10.8.1 of the 2021 Code, an athlete who faces an anti-doping rule violation that carries a period of ineligibility of four or more years may receive a one-year sanction reduction if the athlete admits the violation and accepts the asserted sanction within 20 days of notification of the alleged anti-doping rule violation charge. Per the rule, Adel qualified for a one-year reduction to the otherwise applicable four-year period of ineligibility.
Adel’s three-year period of ineligibility began on November 3, 2021, the date his provisional suspension was imposed. In addition, Adel has been disqualified from all competitive results obtained on and subsequent to October 12, 2021, the date his positive sample was collected, including forfeiture of any medals, points and prizes.
In an effort to aid athletes, as well as support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to file and update athlete Whereabouts, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements, as well as performance-enhancing and recreational drugs.
In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and distributes a multitude of educational materials, such as an easy-reference wallet card with examples of prohibited and permitted substances, a supplement guide, a nutrition guide, an athlete handbook, and periodic alerts and advisories.
USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by text at 87232 (“USADA”), by email at email@example.com, by phone at 1-877-Play Clean (1-877-752-9253) or by mail.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.
For more information or media inquiries, click here.